3.0.0 5155 2023-01-13T22:01:45Z 2023-01-13T22:01:45Z House H HR 2004-09-28 108 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2004-10-08T16:21:31Z Referred to 2004-09-28T16:31:35Z 2004-10-08 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2004-09-28 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2004-09-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2004-09-28 Introduced in House IntroReferral 1000 9 Library of Congress K000336 Rep. Kucinich, Dennis J. [D-OH-10] DENNIS KUCINICH D OH J. 10 N O000159 Rep. Owens, Major R. [D-NY-11] MAJOR OWENS D NY R. 11 2004-09-28 True G000551 Rep. Grijalva, Raúl M. [D-AZ-7] Raúl Grijalva D AZ M. 7 2004-09-28 True C000714 Rep. Conyers, John, Jr. [D-MI-14] JOHN CONYERS D MI 14 2004-09-28 True L000551 Rep. Lee, Barbara [D-CA-9] BARBARA LEE D CA 9 2004-09-28 True S000248 Rep. Serrano, Jose E. [D-NY-16] JOSE SERRANO D NY E. 16 2004-09-28 True D000096 Rep. Davis, Danny K. [D-IL-7] DANNY DAVIS D IL K. 7 2004-09-28 True J000283 Rep. Jackson, Jesse L., Jr. [D-IL-2] JESSE JACKSON D IL L. 2 2004-09-28 True H000627 Rep. Hinchey, Maurice D. [D-NY-22] MAURICE HINCHEY D NY D. 22 2004-10-07 False C000380 Del. Christensen, Donna M. [D-VI-At Large] DONNA CHRISTENSEN D VI M. 0 2004-11-17 False Health Awards, medals, prizes Citizen lawsuits Commemorations Commerce Department of Health and Human Services Drug approvals Drug industry Drugs Economics and Public Finance Electronic government information Executive reorganization Federal aid to research Finance and Financial Sector Government Operations and Politics Government contractors Government paperwork Government property Government publicity Injunctions Intellectual property Internet Law Legal fees Licenses Medical laboratories Medical research Medical supplies National Institutes of Health (NIH) Parties to actions Patents Performance measurement Pharmaceutical research Planning Prescription pricing Research and development Research centers Research grants Science, Technology, Communications Surety and fidelity Web sites Health 00 2004-09-28 Introduced in House 2004-11-30T19:37:16Z Free Market Drug Act - Establishes the National Institute for Biomedical Research and Development to provide for the development of drugs, biological products, and devices to: (1) increase the number and medical efficacy of drugs, biological products, and devices on the market; and (2) make the drugs, biological products, and devices available to the public at reasonable prices.

Requires the Director of the Institute to: (1) monitor the results of certain research to identify discoveries that, if subjected to appropriate research and development activities, may be suitable for approval by the Food and Drug Administration (FDA) as drugs, biological products, or devices for use in humans (candidate discoveries); (2) identify candidate discoveries and carry out appropriate research and development regarding such discoveries; (3) establish, review, and revise a plan for the development, testing, and manufacture of candidate discoveries through the Institute; (4) establish priorities among candidate discoveries; and (5)) maintain an Internet site to make available to the public information on activities under this Act.

Allows the Director to identify a discovery as a candidate discovery only if the Federal Government holds, or can reasonably be expected to obtain, a patent on the discovery. Prohibits the Director from transferring ownership of such patent to any non-Federal entity.

Allows civil suits to protect Federal ownership of patents.

Requires the Director to: (1) grant non-exclusive licenses for the commercial marketing of FDA-approved candidate discoveries; (2) establish Federal laboratories to carry out this Act; and (3) establish a fund to provide cash awards for making significant advances in knowledge regarding a disease, disorder, or other health condition.

]]> Free Market Drug Act Display Title Free Market Drug Act Official Title as Introduced To establish the National Institute for Biomedical Research and Development. Introduced in House IH Short Titles as Introduced Free Market Drug Act Introduced in House 2004-09-28T04:00:00Z 2004-10-08 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.